Presented in part at the American Society of Clinical Oncology Annual Meeting; May 31-June 4, 2013; Chicago, IL.
Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer
Article first published online: 25 MAR 2014
© 2014 American Cancer Society
Volume 120, Issue 13, pages 1939–1947, 1 July 2014
How to Cite
Williams, C. D., Gajra, A., Ganti, A. K. and Kelley, M. J. (2014), Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer. Cancer, 120: 1939–1947. doi: 10.1002/cncr.28679
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veteran Affairs.
- Issue published online: 17 JUN 2014
- Article first published online: 25 MAR 2014
- Manuscript Accepted: 6 FEB 2014
- Manuscript Revised: 5 FEB 2014
- Manuscript Received: 5 NOV 2013
Additional supporting information may be found in the online version of this article.
|cncr28679-sup-0001-supptab1.docx||15K||Supporting Information Table. Odds ratios (OR)a and 95% confidence intervals (95% CI) for the association between demographic and clinical characteristics and receipt of adjuvant chemotherapy among patients with stage IB-IIIA NSCLC, by time period of diagnosis|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.